Camber Pharmaceuticals Launches Generic Marinol®
Piscataway, NJ, February 11, 2020– Camber Pharmaceuticals is pleased to announce the addition of Dronabinol Capsules to our growing portfolio of products.
Dronabinol Capsules is the generic version of Marinol®. Dronbinol is used to nausea and vomiting caused by cancer chemotherapy. Dronabinol is also used to treat loss of appetite and weight loss in people with HIV infection.
Dronabinol Capsules is available in a 2.5, 5, and 10mg- 60ct bottles.
Camber’s commitment to its customers is to bring the highest quality generic pharmaceuticals to the
market and provide a level of excellence in service, supply and affordability.
If you would like more information about this topic, please contact Kirk Hessels at 732.529.0430 or email at [email protected].
Recent articles
- NACDS TSE 2026 Event Recap
- Camber Specialty Marks First Day 1 Injectable Launch
- New to Camber’s Portfolio: Olmesartan medoxomil, Amlodipine and Hydrochlorothiazide Tablets
- Camber Pharmaceuticals Honored as Second Merit Finalist at 2026 DIANA Awards
- Camber Launches Nitazoxanide Tablets
- Cisatracurium Besylate Injection, USP Added to Camber’s Portfolio






